|
|
Lombard Medical Technologies PLC - Comparative Business Analysis Snapshot
Business Description
Lombard Medical Technologies PLC. The Group's principal activity developing medical devices and polymer coatings. The Group's operation focuses on developing, manufacturing and marketing stent grafts for the treatment of abdominal and thoracic aortic aneurysms, endovascular stapling devices for the fixation of stent grafts and percutaneous heart valves, and develops drug delivery coatings. The Group's Aorfix stent graft product addresses the shortcomings of first generation AAA stent grafts which is caused by lack of flexibility and difficulty of application, due to complex delivery systems and the inability of the stent graft to cope with aneurysm remodelling post-implant. The Group's other product is the EndoRefix, an endovascular stapling device applications that includes stent grafts and securing percutaneous heart. It also specialises in biomaterial sciences involved in the development of novel technologies for the healthcare industry.
Competitor Analysis
This analysis compares Lombard Medical Technologies PLC with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
